Why Is CRISPR Therapeutics AG (CRSP) Up 0.2% Since Last Earnings Report?Zacks Investment Research • 12/01/22
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It InsteadThe Motley Fool • 11/25/22
CRISPR Therapeutics Presents Data at the Society for Immunotherapy of Cancer (SITC) 37th Annual MeetingGlobeNewsWire • 11/10/22
CRISPR Therapeutics Announces Poster Presentation on CTX110® at the American Society of Hematology (ASH) 2022 Annual MeetingGlobeNewsWire • 11/03/22
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial ResultsGlobeNewsWire • 11/01/22
CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?Investors Business Daily • 10/20/22
CRISPR Therapeutics to Present at the Society for Immunotherapy of Cancer (SITC) 37th Annual MeetingGlobeNewsWire • 10/05/22
CRISPR Therapeutics to Present at the BMO Biopharma Spotlight Series: Gene Editing and TherapyGlobeNewsWire • 09/29/22